Skip to Content

Zejula Prices, Coupons and Patient Assistance Programs

Zejula (niraparib) is a member of the PARP inhibitors drug class and is commonly used for Fallopian Tube Cancer, Ovarian Cancer and Peritoneal Cancer.

Zejula Prices

This Zejula price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Zejula oral capsule 100 mg is around $15,408 for a supply of 90 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Zejula is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Zejula availability.

Oral Capsule

100 mg Zejula oral capsule
from $15,407.56 for 90 capsule
Quantity Per unit Price
90 $171.20 $15,407.56

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Zejula Coupons and Rebates

Zejula offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Zejula Commercial Co-pay Assistance Program: Eligible patients may have $0 co-pay with savings of up to $26,000 per year; for additional information contact the program at 844-283-7276.

Applies to:Zejula
Number of uses:Per prescription until program expires

Patient Assistance Programs for Zejula

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Zejula (niraparib)

Provider: Together with Tesaro Patient Assistance Program

Elligibility requirements:

  1. Determined case by case
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. US residency requirements are not specified.
  5. This program also provides copay assistance and they will provide a Free First Dose of VARUBI (rolapitant), if there is a delay in coverage determination. Contact the program for more detail.

Applicable drugs:

  • Zejula (niraparib)
Hide